StockNews.AI
EHC
StockNews.AI
21 days

ENCOMPASS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Continuing Investigating Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire is investigating claims against EHC. 2. Federal data shows EHC hospitals perform below average in safety measures. 3. 34 EHC facilities rated worse for preventable readmissions. 4. EHC's stock fell 10.4%, impacting investor confidence. 5. Legal options are being discussed for affected shareholders.

4m saved
Insight
Article

FAQ

Why Very Bearish?

Allegations of poor performance and safety issues can significantly damage investor trust, as seen in similar cases leading to sharp declines in stock prices.

How important is it?

Legal actions and performance allegations against EHC can deter investors and decrease stock prices significantly.

Why Short Term?

The immediate legal implications and negative media coverage can quickly affect EHC's stock value.

Related Companies

HCACYHBKD
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Encompass and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Encompass Health Corporation (“Encompass” or the “Company”) (NYSE:EHC) on behalf of Encompass stockholders. Our investigation concerns whether Encompass has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On July 15, 2025, The New York Times published an article alleging, among other things, that federal data and inspection reports show that for-profit hospitals run by Encompass perform below average on key safety measures. The article revealed “Encompass owns many of the rehabs with worse rates of potentially preventable, unplanned readmissions to general hospitals” including 34 facilities which “Medicare rated as having statistically significantly worse rates of potentially preventable readmissions.” The report further revealed a number of “alarming mistakes” leading to fatalities of patients in their care. On this news, Encompass’s stock price fell $12.39, or 10.4%, to close at $107.28 per share on July 15, 2025, thereby injuring investors. If you purchased or otherwise acquired Encompass shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News